Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,348
datasets available to search
ShareScore release 0.9.0
Dataset results
6,348 results for “Hepatitis”
A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment
ClinicalTrials.gov study NCT00980330. IPD Sharing: Not stated. Countries: 14. Publications: 3.
A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pre
ClinicalTrials.gov study NCT05282121. IPD Sharing: YES. Countries: 16. Publications: 1.
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)
ClinicalTrials.gov study NCT03685708. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants
ClinicalTrials.gov study NCT00528528. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth
ClinicalTrials.gov study NCT00106964. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients
ClinicalTrials.gov study NCT00996476. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
ClinicalTrials.gov study NCT02349048. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
ClinicalTrials.gov study NCT03069365. IPD Sharing: UNDECIDED. Countries: 10. Publications: 2.
Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib
ClinicalTrials.gov study NCT02621047. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
ClinicalTrials.gov study NCT03365635. IPD Sharing: NO. Countries: 1. Publications: 8.
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir
ClinicalTrials.gov study NCT01023217. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
ClinicalTrials.gov study NCT00136318. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients
ClinicalTrials.gov study NCT01636778. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
ClinicalTrials.gov study NCT01745822. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
ClinicalTrials.gov study NCT01922895. IPD Sharing: NO. Countries: 1. Publications: 2.
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
ClinicalTrials.gov study NCT00136214. IPD Sharing: NO. Countries: 1. Publications: 1.
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
ClinicalTrials.gov study NCT01273155. IPD Sharing: NO. Countries: 1. Publications: 3.
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
ClinicalTrials.gov study NCT00307489. IPD Sharing: Not stated. Countries: 4. Publications: 6.
Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon
ClinicalTrials.gov study NCT01542788. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
ClinicalTrials.gov study NCT01369212. IPD Sharing: YES. Countries: 2. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.